Indefinite Delivery Contract SPE2DU25D2017

Award Date 9/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Indefinite Delivery Contract (IDC) SPE2DR25D2104 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This $999,999,999 single-award IDC, running through December 2036, is part of the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) procurement. It aims to establish prime vendor contracts to provide worldwide pharmaceutical support,...
The Indefinite Delivery Contract (IDC) SPE2DU25D3206 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $4,999,999 and runs through December 31, 2036. This IDC is part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) solicitation, which aims to establish multiple prime vendor contracts...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,999,999 contract, with an ultimate completion date of December 31, 2036, is an unrestricted, fully competitive acquisition to establish Pharmaceutical Prime Vendor Global Program Generation V contracts. The purpose is to provide worldwide pharmaceutical support,...
The Indefinite Delivery Contract (IDC) SPE2DR25D2206 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 contract, running through December 2036, is part of the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast...
The federal Indefinite Delivery Contract (IDC) SPE2DU25D1056 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,999,999 contract, which runs through December 2036, aims to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of...
The Indefinite Delivery Contract (IDC) SPE2DR25D7062 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,999,999,999 IDC, running through December 2036, is a prime vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The underlying solicitation, known as the...
The Indefinite Delivery Contract (IDC) SPE2DR25D3012 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 contract, which runs through December 2026, establishes AmerisourceBergen as a Pharmaceutical Prime Vendor to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally....
The Indefinite Delivery Contract (IDC) SPE2DU25D5222 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,999,999 contract covers the period from September 1, 2025 to December 31, 2036, and is designated as a single award with no set-asides. The purpose of this IDC is to establish Prime Vendor Contracts for the Pharmaceutical Prime Vendor Global Program...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,999,999 single-award contract, which runs through December 2036, is part of DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition. The purpose of this IDC is to establish a contract vehicle for Amerisourcebergen to provide worldwide...
The Indefinite Delivery Contract (IDC) SPE2DR25D2105 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines,...

The Indefinite Delivery Contract (IDC) SPE2DU25D2017 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,999,999.00 single-award contract, which runs through December 31, 2036, is part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.

The contract aims to establish pharmaceutical prime vendor agreements to provide worldwide pharmaceutical support, including brand-name, generic, and specialty drugs as well as related medical supplies, to the Department of Defense, Coast Guard, and other designated government agencies and healthcare programs. The contract encompasses a broad range of therapeutic areas, such as cardiovascular health, diabetes management, mental health, pain management, infectious disease prevention, and general medical care. The procurement is unrestricted and fully competitive, with the intention to make multiple awards across regional line items to ensure resiliency and access to vital pharmaceuticals during contingencies or natural disasters.

Generated 6/6/25, 9:58 AM